Alissa Rumin: Starting a New Chapter in Hemophilia and Thrombosis Research
Alissa Rumin, Clinical Research Coordinator at University of Colorado Anschutz, shared a post on LinkedIn:
“I am thrilled to share that I have accepted a Clinical Research Coordinator position at the University of Colorado Anschutz Hemophilia and Thrombosis Center!
This opportunity is especially meaningful as it represents a full-circle moment in my journey.
I wrote my college admission essay about my interest in gene therapy and its potential to improve the lives of those living with bleeding and clotting disorders.
The HTC has supported my family for years, and I am incredibly grateful for the opportunity to give back to this wonderful community.
I owe a huge thank you to my University of Denver professors, advisors, and Principal Investigators, especially Ann Wehman, for the unwavering support, mentorship, and inspiration along the way.
I am beyond excited for this new chapter and look forward to helping patients access the resources they deserve.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 02:51Kassiani Maria Nastouli: Honored to Be Cited in the New ESC Guidelines on the Management of CVD and CKD
-
Sep 5, 2026, 02:44Sedat Gül: Is It Time to Reconsider the 24-Hour Antiplatelet Delay After Thrombolysis?
-
Sep 5, 2026, 02:35Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences